Rani Therapeutics Holdings, Inc. (RANI)

RANI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.22	3.76	5.86	27.01	117.45	73.06
Short-Term Investments	-	23.88	42.68	71.48	-	-
Cash & Short-Term Investments	10.22	27.64	48.54	98.48	117.45	73.06
Cash Growth	-66.94%	-43.06%	-50.71%	-16.15%	60.77%	341.81%
Accounts Receivable	-	0.43	-	-	-	-
Other Receivables	-	-	0.2	-	-	-
Receivables	-	0.43	0.2	-	-	1.72
Prepaid Expenses	0.36	1.18	1.61	1.94	2.14	0.17
Restricted Cash	0.5	0.5	0.5	0.5	-	-
Total Current Assets	11.07	29.74	50.85	100.92	119.6	74.95
Property, Plant & Equipment	5.53	6.64	6.82	7.1	4.61	4.47
Other Long-Term Assets	0.29	0.25	0.25	-	-	-
Total Assets	16.9	36.63	57.92	108.03	124.21	79.42
Accounts Payable	1.8	1.36	0.65	1.46	1.08	0.54
Accrued Expenses	2.55	1.79	1.47	1.76	1.43	0.55
Current Portion of Long-Term Debt	15	15	4.9	-	-	1.36
Current Portion of Leases	1.19	1.46	0.72	1.01	-	-
Current Unearned Revenue	-	-	-	-	-	2.72
Other Current Liabilities	0.09	0.28	0.25	0.59	0.13	0.15
Total Current Liabilities	20.62	19.89	7.99	4.82	2.64	5.31
Long-Term Debt	2.23	9.61	24.48	29.15	-	2.41
Long-Term Leases	3.2	3.64	-	0.06	-	-
Total Liabilities	26.05	33.14	32.47	34.02	2.64	7.72
Common Stock	0.01	0.01	0.01	0.01	0.01	0.66
Additional Paid-In Capital	111.28	104.89	85.76	75.84	55.74	-
Retained Earnings	-116.86	-102.91	-72.89	-38.92	-8.33	-114
Comprehensive Income & Other	0	0.01	-0.01	-0.07	-	-
Total Common Equity	-5.58	1.99	12.87	36.86	47.41	-113.34
Minority Interest	-3.58	1.5	12.58	37.15	74.16	-
Shareholders' Equity	-9.15	3.49	25.44	74	121.57	71.7
Total Liabilities & Equity	16.9	36.63	57.92	108.03	124.21	79.42
Total Debt	21.62	29.71	30.1	30.21	-	3.77
Net Cash (Debt)	-11.4	-2.07	18.44	68.27	117.45	69.29
Net Cash Growth	-	-	-72.99%	-41.88%	69.52%	319.01%
Net Cash Per Share	-0.35	-0.07	0.72	2.87	6.01	1.48
Filing Date Shares Outstanding	47.9	33.51	26.04	25.3	24.39	46.9
Total Common Shares Outstanding	39.24	33.43	26.04	25.3	19.71	46.89
Working Capital	-9.55	9.85	42.86	96.11	116.96	69.64
Book Value Per Share	-0.14	0.06	0.49	1.46	2.41	-2.42
Tangible Book Value	-5.58	1.99	12.87	36.86	47.41	-113.34
Tangible Book Value Per Share	-0.14	0.06	0.49	1.46	2.41	-2.42
Machinery	-	4.4	4.18	2.82	1.78	1.64
Construction In Progress	-	0.03	3.9	4.42	3.87	3.48
Leasehold Improvements	-	1.66	1.59	1.55	1.23	1.12

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q